FDMT - 4D Molecular Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FDMT is currently covered by 9 analysts with an average price target of $29.52. This is a potential upside of $25.9 (715.47%) from yesterday's end of day stock price of $3.62.

4D Molecular Therapeutics 's activity chart (see below) currently has 22 price targets and 58 ratings on display. The stock rating distribution of FDMT is 92.86% BUY, 2.38% HOLD and 4.76% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.27% with an average time for these price targets to be met of 98.33 days.

Highest price target for FDMT is $44, Lowest price target is $6, average price target is $32.71.

Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN SACHS on 09-May-2025. First documented stock forecast 05-Jan-2021.

Currently out of the existing stock ratings of FDMT, 39 are a BUY (92.86%), 1 are a HOLD (2.38%), 2 are a SELL (4.76%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$44

$40.38 (1115.47%)

23 days ago
(09-May-2025)

0/3 (0%)

$40.92 (1328.57%)

Buy

$40

$36.38 (1004.97%)

2 months 22 days ago
(10-Mar-2025)

1/2 (50%)

$36.1 (925.64%)

243

Buy

$28

$24.38 (673.48%)

2 months 28 days ago
(04-Mar-2025)

3/6 (50%)

$24.03 (605.29%)

201

Buy

$36

$32.38 (894.48%)

2 months 29 days ago
(03-Mar-2025)

0/15 (0%)

$31.47 (694.70%)

Buy

$35

$31.38 (866.85%)

$39

2 months 29 days ago
(03-Mar-2025)

2/7 (28.57%)

$30.47 (672.63%)

29

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FDMT (4D Molecular Therapeutics ) average time for price targets to be met?

On average it took 98.33 days on average for the stock forecasts to be realized with a an average price target met ratio 33.27

Which analyst has the current highest performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

GEULAH LIVSHITS

Which analyst has the current lower performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

TAZEEN AHMAD

Which analyst has the most public recommendations on FDMT (4D Molecular Therapeutics )?

Geulah Livshits works at CHARDAN CAPITAL and has 11 price targets and 12 ratings on FDMT

Which analyst is the currently most bullish on FDMT (4D Molecular Therapeutics )?

Salveen Richter with highest potential upside - $40.38

Which analyst is the currently most reserved on FDMT (4D Molecular Therapeutics )?

Mani Foroohar with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?